TyG Index Explained: A Simple Insulin Resistance Estimate

No insulin test required. The TyG Index estimates insulin resistance using two numbers from a standard lipid and glucose panel most people already have.

Quick answer: The TyG Index (Triglyceride-Glucose Index) is a calculation combining fasting triglycerides and fasting glucose to estimate insulin resistance. Unlike HOMA-IR, it doesn't require a fasting insulin test, making it easier to calculate from a standard panel. Research generally associates values above roughly 4.5 to 4.9 with a higher likelihood of insulin resistance, though exact cutoffs vary by population and study.

How the TyG Index is calculated

The formula is: Ln[Fasting Triglycerides (mg/dL) x Fasting Glucose (mg/dL) / 2], where Ln refers to the natural logarithm. Both values come from a standard fasting lipid and glucose panel, which is part of why this index has become popular in research as a practical alternative to insulin-based calculations like HOMA-IR.

Why it doesn't need an insulin test

Fasting insulin assays can vary between labs and aren't part of routine panels by default, which limits how widely HOMA-IR can be used in everyday screening. Triglycerides and glucose, by contrast, are already included in most standard lipid and metabolic panels. Research has found that the relationship between triglycerides, glucose, and insulin resistance is consistent enough that the TyG Index correlates reasonably well with more invasive insulin-based measurements in many studies.

Reading your result

General research-based reference points suggest values below approximately 4.5 are associated with lower likelihood of insulin resistance, while values above roughly 4.9 are associated with higher likelihood, with a transitional zone in between. These cutoffs vary somewhat between studies and populations, so the number is more useful as a directional signal, and for tracking change over time, than as a fixed diagnostic threshold.

Why triglycerides and glucose are connected in the first place

Insulin resistance affects both markers through related pathways. Impaired insulin signaling reduces the liver's ability to properly regulate triglyceride production, often raising triglyceride levels, while also impairing glucose uptake by cells, raising blood glucose. Because both shifts stem from the same underlying insulin resistance, combining them into one index captures more information than either number alone.

TyG Index versus HOMA-IR: which should you use?

They're not competing tools so much as different options depending on what data you have. If you already have fasting insulin from a prior test, HOMA-IR is a direct, established option. If you only have a standard lipid and glucose panel, which is far more common, TyG Index gives you a reasonable estimate without needing an additional test. Some people track both when data is available, since they can occasionally diverge.

Frequently asked questions

Is the TyG Index as accurate as HOMA-IR?

Research generally shows reasonable correlation between the two, though they're not interchangeable. TyG Index has the practical advantage of not requiring an insulin test, while HOMA-IR uses a more direct measurement of insulin itself.

Can high triglycerides alone raise my TyG Index without insulin resistance?

Triglycerides can be elevated by factors other than insulin resistance, including diet, alcohol intake, and certain genetic conditions, which is why TyG Index is an estimate rather than a definitive insulin resistance diagnosis.

Do I need to fast before this test?

Yes. Both triglycerides and glucose need to be measured after a fasting period, typically 8 to 12 hours, for the calculation to be meaningful. Non-fasting values will produce an inaccurate result.

The Metabolic Clarity takeaway

The TyG Index turns numbers you likely already have into a useful estimate of insulin resistance, no extra blood draw required.

Next step: Use the TyG Index Calculator with your last fasting labs, and read the Complete Guide to Insulin Resistance for the bigger picture.

Sources

Charles Kirkland is the founder of Metabolic Clarity Labs. He is not a physician. His writing is based on his own documented health experience, alongside cited research sources.

Medical and regulatory disclaimer: This article is for general education only. It does not diagnose, treat, or prevent disease and does not replace advice from a physician or other qualified health professional.

Back to blog